Rod Flynn, MD – Director of the Peritoneal Surface Malignancy Treatment/HIPEC Program
Learn More About HIPEC Physicians at CTCA: Chat with Us | Email Us
University of Maryland School of Medicine, Baltimore
Internship / Residency
General Surgery - Allegheny University Hospitals, Philadelphia
General Surgery - Graduate Hospital, Philadelphia
Surgical Oncology - University of Pittsburgh Medical Center
Diplomate, American Board of Surgery
"I work for each patient and treat them as a person first, and a patient second. I strive to honor their wishes and attempt to improve and increase the quality and quantity of their lives."
Dr. Rod Flynn
Director of the Peritoneal Surface Malignancy Treatment/HIPEC Program & Surgical Oncologist
“I consider myself a servant to my patients, with the overall goal to treat each patient in the most dignified and professional manner possible,” says Dr. Rod Flynn, a board-certified surgical oncologist. “I am a partner in each of my patients’ journeys with cancer.”
Dr. Flynn joined Cancer Treatment Centers of America (CTCA) in June 2012 to lead CTCA in Philadelphia’s Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program. He says, “I am excited to work with a team of experts who are dedicated to pursuing innovative strategies to treat our patients.”
Dr. Flynn notes, “HIPEC is an example of a regional therapy that involves treating abdominal surface tumors with a heated chemotherapy solution. The chemotherapy is delivered directly to the abdomen immediately following surgery to remove visible abdominal tumors. It may be used to treat some cases of colorectal, ovarian, stomach and primary peritoneal cancer.”
“HIPEC is an aggressive treatment for a very aggressive disease process,” he emphasizes. “It offers hope to patients who were otherwise told they had none.”
Dr. Flynn performs complex and advanced surgery for peritoneal tumors, as well as cancer of the stomach, colon, rectum, liver and pancreas. He also performs surgical procedures to treat skin cancer, soft tissue sarcomas and endocrine tumors.
A Diplomate of the American Board of Surgery, Dr. Flynn earned a medical degree from the University of Maryland School of Medicine in Baltimore. He completed a general surgery internship at Allegheny University hospitals in Philadelphia, followed by a general surgery residency at Graduate Hospital in Philadelphia. Dr. Flynn then fulfilled a surgical oncology fellowship at the University of Pittsburgh Medical Center.
While at Graduate Hospital, he garnered awards for “Best Surgical Resident,” “Best Teaching Resident” and “Most Outstanding Chief Resident.”
Dr. Flynn obtained a bachelor’s degree in chemistry/biochemistry from the University of Virginia before studying medicine.
Prior to his role at CTCA, Dr. Flynn served as a surgical oncologist and general surgeon at hospitals in the Washington, D.C. /Baltimore metropolitan area. He also served on several hospital committees.
In 2012, Dr. Flynn was recognized by Northern Virginia Magazine as a top doctor in surgery. He is a member of the American Medical Association, the Society of Surgical Oncology and the American College of Surgeons.